This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. to supply a variety of standard pediatric vaccines over a 12-month period. The contract, valued at up to $1,530,970,000, will support the CDC's Vaccines for Children program, which provides immunizations to eligible children.
The contract covers 20 different pediatric vaccines, including DTaP, Hepatitis A and B, Hib, HPV, MMR, Pneumococcal, Rotavirus, and Varicella, with minimum and maximum quantities ranging from 100 doses to 13 million doses per item. The vaccines will be shipped F.O.B. Destination to the 50 U.S. states and territories. This acquisition was conducted as a commercial item procurement under FAR Part 12, with no set-aside designations used. The contract allows Pfizer, a large pharmaceutical manufacturer, to supply a diverse array of critical pediatric vaccines to support the CDC's public health initiatives.
Generated 12/17/24, 9:05 AM